Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Radiology
    October 2022
  1. EMMONS EC, Bishay S, Du L, Krebs H, et al
    Survival and Toxicities after (90)Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry.
    Radiology. 2022;305:228-236.
    >> Share

    September 2022
  2. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022 Sep 27:221149. doi: 10.1148/radiol.221149.
    >> Share

  3. GHELFI J, Decaens T, Macek Jilkova Z
    Rat Model of Hepatocellular Carcinoma for Better Understanding Immune Effects of Transarterial Chemoembolization.
    Radiology. 2022 Sep 6:220179. doi: 10.1148/radiol.220179.
    >> Share

  4. VALENCIA SA, Romero JA
    Limitations of a Multiparametric US Score for NASH Prediction.
    Radiology. 2022;304:E50.
    >> Share

    August 2022
  5. XIE J, Wei X
    Cirrhosis-related Spontaneous Mesocaval Shunt.
    Radiology. 2022 Aug 23:220564. doi: 10.1148/radiol.220564.
    >> Share

  6. KWAG M, Choi SH, Choi SJ, Byun JH, et al
    Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
    Radiology. 2022 Aug 16:220659. doi: 10.1148/radiol.220659.
    >> Share

  7. CHOI SJ, Lee SS, Jung KH, Lee JB, et al
    Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
    Radiology. 2022 Aug 9:220536. doi: 10.1148/radiol.220536.
    >> Share

  8. LUQUE-CABAL M, Alvarez-Guisasola V, Rizzo-Raza S, Sales-Fernandez C, et al
    Case 304: Porphyria Cutanea Tarda.
    Radiology. 2022;304:488-492.
    >> Share

  9. TORKIAN P, Akhlaghpoor S
    Considerations Regarding Image-guided Treatment of Liver Hemangioma.
    Radiology. 2022;304:E45.
    >> Share

  10. YAN Y
    Three-dimensional MR Elastography in Distinguishing Necroinflammation from Liver Fibrosis.
    Radiology. 2022;304:E43.
    >> Share

  11. BARR RG
    US-targeted Microbubbles to Assess Liver Fibrosis.
    Radiology. 2022;304:483-484.
    >> Share

    July 2022
  12. DUBINSKY TJ
    Evaluating Hepatic Steatosis with MRI as the Reference Standard: Different Performances of Three US Machines.
    Radiology. 2022 Jul 12:221177. doi: 10.1148/radiol.221177.
    >> Share

    June 2022
  13. JANG JK, Lee ES, Seo JW, Kim YR, et al
    Two-dimensional Shear-Wave Elastography and US Attenuation Imaging for Nonalcoholic Steatohepatitis Diagnosis: A Cross-sectional, Multicenter Study.
    Radiology. 2022 Jun 21:220220. doi: 10.1148/radiol.220220.
    >> Share

  14. GAO RZ, Sun WB, Gao J
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: Is It a Promising Treatment for Giant Liver Hemangioma?
    Radiology. 2022;303:E39.
    >> Share

  15. RONOT M
    Performance of LI-RADS for the Noninvasive Diagnosis of HCC: Pathology Should Not Be the Only Acceptable Reference.
    Radiology. 2022;303:546-547.
    >> Share

    May 2022
  16. KHANNA G, Alazraki AL
    Quantitative US versus Quantitative MRI in the Assessment of Pediatric Chronic Liver Disease.
    Radiology. 2022 May 24:221066. doi: 10.1148/radiol.221066.
    >> Share

  17. ALVES VPV, Dillman JR, Tkach JA, Bennett PS, et al
    Comparison of Quantitative Liver US and MRI in Patients with Liver Disease.
    Radiology. 2022 May 24:212995. doi: 10.1148/radiol.212995.
    >> Share

  18. RAMAN AG, Jones C, Weiss CR
    Machine Learning for Hepatocellular Carcinoma Segmentation at MRI: Radiology In Training.
    Radiology. 2022 May 10:212386. doi: 10.1148/radiol.212386.
    >> Share

  19. MIAO X, Sha T, Zhang W, Zhou H, et al
    Liver Fibrosis Assessment by Viewing Sinusoidal Capillarization: US Molecular Imaging versus Two-dimensional Shear-Wave Elastography in Rats.
    Radiology. 2022 May 3:212325. doi: 10.1148/radiol.212325.
    >> Share

    April 2022
  20. BORDE T, Nezami N, Gaupp FL, Savic LJ, et al
    Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.
    Radiology. 2022 Apr 12:212426. doi: 10.1148/radiol.212426.
    >> Share

  21. WHITE SB
    The Immune Response: A New Frontier in Interventional Oncology.
    Radiology. 2022;303:229-230.
    >> Share

  22. ATRI M, Jang HJ, Kim TK, Khalili K, et al
    Contrast-enhanced US of the Liver and Kidney: A Problem-solving Modality.
    Radiology. 2022;303:11-25.
    >> Share

  23. KENNEDY P, Marron TU, Taouli B
    Is There an Impact of Locoregional Therapy on Immune Response Modulation in HCC?
    Radiology. 2022;303:226-228.
    >> Share

    March 2022
  24. ITO K
    US-derived Fat Fraction Screening of Hepatic Steatosis.
    Radiology. 2022 Mar 29:213052. doi: 10.1148/radiol.213052.
    >> Share

  25. JUNG J, Han A, Madamba E, Bettencourt R, et al
    Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.
    Radiology. 2022 Mar 29:211131. doi: 10.1148/radiol.211131.
    >> Share

  26. LEE JT
    Sarcopenia at Abdominal CT in Patients with Cirrhosis.
    Radiology. 2022 Mar 15:220191. doi: 10.1148/radiol.220191.
    >> Share

  27. ZAFAR F, Lubert AM, Trout AT, Katz DA, et al
    Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation.
    Radiology. 2022 Mar 15:211037. doi: 10.1148/radiol.211037.
    >> Share

  28. LIU J, Ma J, Yang C, Chen M, et al
    Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
    Radiology. 2022 Mar 15:211172. doi: 10.1148/radiol.211172.
    >> Share

  29. DHONDT E, Lambert B, Hermie L, Huyck L, et al
    (90)Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.
    Radiology. 2022 Mar 8:211806. doi: 10.1148/radiol.211806.
    >> Share

  30. VAN DER POL CB, McInnes MDF, Salameh JP, Chernyak V, et al
    Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
    Radiology. 2022 Mar 1:212340. doi: 10.1148/radiol.212340.
    >> Share

  31. DUAN L, Zhang BH, Zheng XH
    No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma.
    Radiology. 2022 Mar 1:211994. doi: 10.1148/radiol.211994.
    >> Share

    February 2022
  32. CHUNG JW
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of New Systemic Agents.
    Radiology. 2022 Feb 1:212826. doi: 10.1148/radiol.212826.
    >> Share

  33. ZHENG K, Zhu X, Fu S, Cao G, et al
    Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
    Radiology. 2022 Feb 1:211545. doi: 10.1148/radiol.211545.
    >> Share

    January 2022
  34. FERRAIOLI G, Kumar V, Ozturk A, Nam K, et al
    US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.
    Radiology. 2022 Jan 25:210736. doi: 10.1148/radiol.210736.
    >> Share

  35. TISCHFIELD DJ, Gurevich A, Johnson O, Gatmaytan I, et al
    Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.
    Radiology. 2022 Jan 11:211028. doi: 10.1148/radiol.211028.
    >> Share

  36. JENSEN CT, Gupta S, Saleh MM, Liu X, et al
    Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
    Radiology. 2022 Jan 11:211838. doi: 10.1148/radiol.211838.
    >> Share

    December 2021
  37. LOCKHART ME
    NASH Diagnosis Made Better but Maybe Not Yet Easier.
    Radiology. 2021;301:635-636.
    >> Share

  38. SUGIMOTO K, Lee DH, Lee JY, Yu SJ, et al
    Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study.
    Radiology. 2021;301:625-634.
    >> Share

    November 2021
  39. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
    >> Share

  40. MARTI-AGUADO D, Jimenez-Pastor A, Alberich-Bayarri A, Rodriguez-Ortega A, et al
    Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Radiology. 2021 Nov 16:211027. doi: 10.1148/radiol.2021211027.
    >> Share

  41. DING PX, Lee EW
    Spontaneous Portosystemic Shunt with Budd-Chiari Syndrome.
    Radiology. 2021;301:282.
    >> Share

  42. AYOOBI YAZDI N, Mehrabinejad MM, Dashti H, Pourghorban R, et al
    Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Radiology. 2021;301:464-471.
    >> Share

    October 2021
  43. PEREZ AA, Noe-Kim V, Lubner MG, Graffy PM, et al
    Deep Learning CT-based Quantitative Visualization Tool for Liver Volume Estimation: Defining Normal and Hepatomegaly.
    Radiology. 2021 Oct 26:210531. doi: 10.1148/radiol.2021210531.
    >> Share

  44. REEDER SB
    Emergence of 3D MR Elastography-based Quantitative Markers for Diffuse Liver Disease.
    Radiology. 2021;301:163-165.
    >> Share

  45. SOULEN MC, Garcia-Monaco R
    Closing the Gap in Curative Ablation of Liver Cancer.
    Radiology. 2021;301:237-238.
    >> Share

    September 2021
  46. MORRELL GR
    Detection of Tumor Thrombus in Hepatocellular Carcinoma.
    Radiology. 2021 Sep 28:211984. doi: 10.1148/radiol.2021211984.
    >> Share

  47. BAE JS, Lee JM, Jeon SK, Yoo J, et al
    LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
    Radiology. 2021 Sep 28:210215. doi: 10.1148/radiol.2021210215.
    >> Share

  48. YU MM, Tang XL, Jin H, Yang S, et al
    Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
    Radiology. 2021 Sep 21:210355. doi: 10.1148/radiol.2021210355.
    >> Share

  49. STAREKOVA J, Hernando D, Pickhardt PJ, Reeder SB, et al
    Quantification of Liver Fat Content with CT and MRI: State of the Art.
    Radiology. 2021 Sep 21:204288. doi: 10.1148/radiol.2021204288.
    >> Share

    August 2021
  50. ZHANG T, Zhang G, Deng X, Zeng J, et al
    APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Radiology. 2021 Aug 24:204700. doi: 10.1148/radiol.2021204700.
    >> Share

  51. SHI Y, Qi YF, Lan GY, Wu Q, et al
    Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.
    Radiology. 2021 Aug 10:202804. doi: 10.1148/radiol.2021202804.
    >> Share

    July 2021
  52. LEE DH, Lee MW, Kim PN, Lee YJ, et al
    Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Radiology. 2021 Jul 27:210309. doi: 10.1148/radiol.2021210309.
    >> Share

  53. HE KS, Fernando R, Cabrera T, Valenti D, et al
    Hepatic Hilar Nerve Block for Hepatic Interventions: Anatomy, Technique, and Initial Clinical Experience in Thermal Ablation of Liver Tumors.
    Radiology. 2021 Jul 13:203410. doi: 10.1148/radiol.2021203410.
    >> Share

  54. KRINSKY G, Shanbhogue K
    Proliferative versus Nonproliferative Hepatocellular Carcinoma: Clinical and Imaging Implications.
    Radiology. 2021 Jul 6:211316. doi: 10.1148/radiol.2021211316.
    >> Share

  55. KANG HJ, Kim H, Lee DH, Hur BY, et al
    Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.
    Radiology. 2021 Jul 6:204352. doi: 10.1148/radiol.2021204352.
    >> Share

    June 2021
  56. JIANG H, Chen HC, Lafata KJ, Bashir MR, et al
    Week 4 Liver Fat Reduction on MRI as an Early Predictor of Treatment Response in Participants with Nonalcoholic Steatohepatitis.
    Radiology. 2021 Jun 1:204325. doi: 10.1148/radiol.2021204325.
    >> Share

  57. DU J, Bydder GM
    Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
    Radiology. 2021;299:673-674.
    >> Share

    May 2021
  58. BAI XM, Cui M, Yang W, Wang H, et al
    The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Radiology. 2021 May 18:200153. doi: 10.1148/radiol.2021200153.
    >> Share

  59. YOON JH, Kim H
    CT Characterization of Aggressive Macrotrabecular-Massive Hepatocellular Carcinoma: A Step Forward to Personalized Medicine.
    Radiology. 2021 May 11:210379. doi: 10.1148/radiol.2021210379.
    >> Share

  60. FENG Z, Li H, Zhao H, Jiang Y, et al
    Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
    Radiology. 2021 May 11:203614. doi: 10.1148/radiol.2021203614.
    >> Share

  61. MEIJERINK MR, Ruarus AH, Vroomen LGPH, Puijk RS, et al
    Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Radiology. 2021;299:470-480.
    >> Share

    April 2021
  62. PAISANT A, Gillard M, Oberti F, Roux M, et al
    Validation of a Diagnostic Algorithm for Hepatocellular Carcinoma at Gadoxetic Acid-enhanced MRI.
    Radiology. 2021 Apr 27:204529. doi: 10.1148/radiol.2021204529.
    >> Share

  63. LV J, Xu Y, Xu L, Nie L, et al
    Quantitative Functional Evaluation of Liver Fibrosis in Mice with Dynamic Contrast-enhanced Photoacoustic Imaging.
    Radiology. 2021 Apr 27:204134. doi: 10.1148/radiol.2021204134.
    >> Share

  64. LUZ JHM, Veloso Gomes F, Costa NV, Vasco I, et al
    BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
    Radiology. 2021 Apr 6:204055. doi: 10.1148/radiol.2021204055.
    >> Share

    March 2021
  65. O'SHEA A, Pierce TT
    US Elastography in Hepatic Fibrosis-Radiology In Training.
    Radiology. 2021 Mar 23:203893. doi: 10.1148/radiol.2021203893.
    >> Share

  66. DUSEK P, Lescinskij A, Ruzicka F, Acosta-Cabronero J, et al
    Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
    Radiology. 2021 Mar 23:202846. doi: 10.1148/radiol.2021202846.
    >> Share

  67. BAE JS, Lee JM, Yoon JH, Kang HJ, et al
    Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
    Radiology. 2021 Mar 2:203537. doi: 10.1148/radiol.2021203537.
    >> Share

  68. BASHIR MR, Mendiratta-Lala M
    CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
    Radiology. 2021 Mar 2:210049. doi: 10.1148/radiol.2021210049.
    >> Share

    February 2021
  69. PALTIEL HJ
    LI-RADS Version 2018 Is of Limited Use in the Diagnosis of Hepatocellular Carcinoma in Children.
    Radiology. 2021 Feb 23:204480. doi: 10.1148/radiol.2021204480.
    >> Share

  70. KHANNA G, Chavhan GB, Schooler GR, Fraum TJ, et al
    Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
    Radiology. 2021 Feb 23:203559. doi: 10.1148/radiol.2021203559.
    >> Share

  71. NARDELLI S, Riggio O, Turco L, Gioia S, et al
    Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis.
    Radiology. 2021 Feb 2:203051. doi: 10.1148/radiol.2021203051.
    >> Share

  72. REEDER SB
    Portosystemic Shunts: Should We Pay Closer Attention with Cross-Sectional Imaging?
    Radiology. 2021 Feb 2:204282. doi: 10.1148/radiol.2021204282.
    >> Share

    January 2021
  73. KARMEGARAJ B
    Normal Fetal Umbilical, Portal, and Hepatic Venous System: Four-dimensional STIC Rendering.
    Radiology. 2021 Jan 26:203300. doi: 10.1148/radiol.2021203300.
    >> Share

  74. MADOFF DC, Cornman-Homonoff J, Fortune BE, Gaba RC, et al
    Management of Refractory Ascites Due to Portal Hypertension: Current Status.
    Radiology. 2021 Jan 26:201960. doi: 10.1148/radiol.2021201960.
    >> Share

  75. CHEN S, Peng Z, Zhang Y, Chen M, et al
    Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
    Radiology. 2021 Jan 19:202289. doi: 10.1148/radiol.2021202289.
    >> Share

  76. HU HH, Yokoo T, Bashir MR, Sirlin CB, et al
    Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study.
    Radiology. 2021 Jan 19:202912. doi: 10.1148/radiol.2021202912.
    >> Share

  77. CHANDARANA H, Shanbhogue K
    Noninvasive Staging of Liver Fibrosis with Dual-Energy CT: Close but No Cigar.
    Radiology. 2021 Jan 5:204315. doi: 10.1148/radiol.2021204315.
    >> Share

  78. MARRI UK, Das P, Shalimar, Kalaivani M, et al
    Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
    Radiology. 2021 Jan 5:202232. doi: 10.1148/radiol.2021202232.
    >> Share

  79. KIESSLING F
    US Microbubbles as Smart Sensors of Portal Venous Pressure.
    Radiology. 2021;298:112-113.
    >> Share

  80. HAN K, Kim JH, Yang SG, Park SH, et al
    A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Radiology. 2021;298:212-218.
    >> Share

  81. KANG TW, Jeong WK, Kim YY, Min JH, et al
    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia.
    Radiology. 2021;298:82-90.
    >> Share

    December 2020
  82. EISENBREY JR, Forsberg F, Wessner CE, Delaney LJ, et al
    US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.
    Radiology. 2020 Dec 15:202321. doi: 10.1148/radiol.2020202321.
    >> Share

    November 2020
  83. ROSTAMBEIGI N, Farsad K, Young S, Shrestha P, et al
    Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study.
    Radiology. 2020 Nov 17:201690. doi: 10.1148/radiol.2020201690.
    >> Share

  84. GUPTA I, Eisenbrey JR, Machado P, Stanczak M, et al
    Diagnosing Portal Hypertension with Noninvasive Subharmonic Pressure Estimates from a US Contrast Agent.
    Radiology. 2020 Nov 17:202677. doi: 10.1148/radiol.2020202677.
    >> Share

  85. FRULIO N, Balabaud C, Trillaud H, Bioulac-Sage P, et al
    Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
    Radiology. 2020 Nov 10:203244. doi: 10.1148/radiol.2020203244.
    >> Share

  86. SOULEN MC, Sofocleous CT
    Achieving Curative Ablation Outcomes: It Is All about the Imaging.
    Radiology. 2020 Nov 10:203930. doi: 10.1148/radiol.2020203930.
    >> Share

    October 2020
  87. FETZER DT
    Recent Advances in US Vascular Imaging: Highlighting an Important Use Case.
    Radiology. 2020 Oct 27:203830. doi: 10.1148/radiol.2020203830.
    >> Share

  88. BASHIR MR
    Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI?
    Radiology. 2020 Oct 6:203631. doi: 10.1148/radiol.2020203631.
    >> Share

  89. NAKAI Y, Gonoi W, Kurokawa R, Nishioka Y, et al
    MRI Findings of Liver Parenchyma Peripheral to Colorectal Liver Metastasis: A Potential Predictor of Long-term Prognosis.
    Radiology. 2020 Oct 6:202367. doi: 10.1148/radiol.2020202367.
    >> Share

  90. DAVARPANAH AH, Eberhardt LW
    Case 282: Fishbone Pylephlebitis.
    Radiology. 2020;297:239-243.
    >> Share

  91. DE ROOS A, Lamb HJ
    Exploring the Interaction between Liver and Heart Disease.
    Radiology. 2020;297:62-63.
    >> Share

  92. WEISS CR, Nezami N
    One Step Closer to Precision Medicine for Transarterial Therapy of HCC.
    Radiology. 2020;297:235-236.
    >> Share

    September 2020
  93. TANG A
    Using MRI to Assess Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:203376. doi: 10.1148/radiol.2020203376.
    >> Share

  94. WANG F, Numata K, Ruan L
    Accurate Assessment of Vascularity of Focal Hepatic Lesions in Arterial Phase Imaging.
    Radiology. 2020 Sep 29:202780. doi: 10.1148/radiol.2020202780.
    >> Share

  95. MIN JH, Lee MW, Park HS, Lee DH, et al
    Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
    Radiology. 2020 Sep 29:201940. doi: 10.1148/radiol.2020201940.
    >> Share

  96. DO RK, Mendiratta-Lala M
    Moving Away from Uncertainty: A Potential Role for Ancillary Features in LI-RADS Treatment Response.
    Radiology. 2020;296:562-563.
    >> Share

  97. SOFOCLEOUS CT, Vasiniotis Kamarinos N
    Tumor Radiation-absorbed Dose: The Missing Link in Radioembolization.
    Radiology. 2020;296:685-686.
    >> Share

    August 2020
  98. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 25:209017. doi: 10.1148/radiol.2020209017.
    >> Share

  99. ISAAK A, Praktiknjo M, Jansen C, Faron A, et al
    Myocardial Fibrosis and Inflammation in Liver Cirrhosis: MRI Study of the Liver-Heart Axis.
    Radiology. 2020 Aug 18:201057. doi: 10.1148/radiol.2020201057.
    >> Share

  100. ZIV E, Zhang Y, Kelly L, Nikolovski I, et al
    NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation.
    Radiology. 2020 Aug 11:200201. doi: 10.1148/radiol.2020200201.
    >> Share

  101. KANG HJ, Lee JM, Yoon JH, Lee K, et al
    Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Radiology. 2020 Aug 4:200115. doi: 10.1148/radiol.2020200115.
    >> Share

  102. KIM TK, Jang HJ
    Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma.
    Radiology. 2020 Aug 4:202763. doi: 10.1148/radiol.2020202763.
    >> Share

    July 2020
  103. PARK S, Joo I, Lee DH, Bae JS, et al
    Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
    Radiology. 2020 Jul 21:192797. doi: 10.1148/radiol.2020192797.
    >> Share

  104. SAVIC LJ, Doemel LA, Schobert IT, Montgomery RR, et al
    Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?
    Radiology. 2020 Jul 7:200373. doi: 10.1148/radiol.2020200373.
    >> Share

    June 2020
  105. SCHOOLER GR, Squires JH, Alazraki A, Chavhan GB, et al
    Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group.
    Radiology. 2020 Jun 30:200751. doi: 10.1148/radiol.2020200751.
    >> Share

  106. HERMANN AL, Dieudonne A, Ronot M, Sanchez M, et al
    Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with (90)Y in the SARAH Study.
    Radiology. 2020 Jun 30:191606. doi: 10.1148/radiol.2020191606.
    >> Share

  107. SUGIMOTO K, Moriyasu F, Oshiro H, Takeuchi H, et al
    The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Jun 23:192665. doi: 10.1148/radiol.2020192665.
    >> Share

  108. BARR RG, Wilson SR, Rubens D, Garcia-Tsao G, et al
    Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement.
    Radiology. 2020 Jun 9:192437. doi: 10.1148/radiol.2020192437.
    >> Share

  109. MOTOSUGI U
    Treat or Wait? Hepatobiliary Phase Hypointense Nodule without Arterial Phase Hyperenhancement.
    Radiology. 2020 Jun 2:201726. doi: 10.1148/radiol.2020201726.
    >> Share

  110. JOO I, Kim SY, Kang TW, Kim YK, et al
    Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Radiology. 2020 Jun 2:192275. doi: 10.1148/radiol.2020192275.
    >> Share

    May 2020
  111. GIORGIO A, De Luca M, Gatti P, Matteucci P, et al
    CEUS LI-RADS Categories to Distinguish Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma Malignancies.
    Radiology. 2020 May 12:200623. doi: 10.1148/radiol.2020200623.
    >> Share

  112. LOCKHART ME, Smith AD
    Fatty Liver Disease: Artificial Intelligence Takes on the Challenge.
    Radiology. 2020;295:351-352.
    >> Share

    April 2020
  113. ZHOU IY, Clavijo Jordan V, Rotile NJ, Akam E, et al
    Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis.
    Radiology. 2020 Apr 28:192118. doi: 10.1148/radiol.2020192118.
    >> Share

    March 2020
  114. MULE S, Galletto Pregliasco A, Tenenhaus A, Kharrat R, et al
    Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
    Radiology. 2020 Mar 31:192230. doi: 10.1148/radiol.2020192230.
    >> Share

    February 2020
  115. HAN A, Byra M, Heba E, Andre MP, et al
    Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
    Radiology. 2020 Feb 25:191160. doi: 10.1148/radiol.2020191160.
    >> Share

  116. KONO Y, Sirlin CB, Fetzer DT, Kim TK, et al
    Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US.
    Radiology. 2020 Feb 18:192557. doi: 10.1148/radiol.2020192557.
    >> Share

  117. KROMREY ML, Le Bihan D, Ichikawa S, Motosugi U, et al
    Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
    Radiology. 2020 Feb 11:191498. doi: 10.1148/radiol.2020191498.
    >> Share

  118. DO RK, Mendiratta-Lala M
    LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating.
    Radiology. 2020;294:327-328.
    >> Share

    November 2019
  119. BASTATI N, Beer L, Mandorfer M, Poetter-Lang S, et al
    Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?
    Radiology. 2019 Nov 19:190734. doi: 10.1148/radiol.2019190734.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016